Store Brand OTC Sales Rise as J&J Recalls More Products

July 13, 2010

Store brand sales of over-the-counter (OTC) pain and allergy remedies are rising as Johnson & Johnson sales collapsing as it recalls even more products, including regular Tylenol and now Benadryl.

tylenol Over the past month, OTC store brands have increased 23 percent to $51.9 million as J&J’s sales have plunged 56 percent, according to Symphony IRI Group data quoted by the Associated Press.
Shoppers are becoming more wary of purchasing J&J products as the company announced its eight recall this week, which included 21 more lots of Tylenol, Children’s Tylenol and Benadryl.

On April 30 more than 130 million bottles of infant and children’s cold formulas were recalled due to a chemical used on shipping pallets that caused nausea. The company said new lots were added this week when it was discovered that these products were also shipped stored on the same type of wooden pallets, according to the report.

Read These Related Articles:

Keywords: benadryl, business, companies, food and beverage, industry, johnson & johnson, markets, mcneil consumer healthcare, private label drugs, private label health care products, private label non-foods, store brand drugs, store brand health care products, store brand non-foods, tylenol

Comments - Post a Comment

Post A Comment
Name:	(*Required)
Email:	(*Required) - Not Displayed With Comment
Website:
Comment:

« View All Articles

Guest Columns

Grocery Aisle Innovation Key to Retailer and Consumer Cost Savings

Retailers are redesigning the aisle, appealing to environmentally friendly consumers and capitalizing on market trends to make their private label brands more competitive.

Source: Tetra Pak Inc.

How to Develop a Private Label Expression Aligned with Retail Brand Strategy

By creating private label as a marketing tool rather than just a price alternative, retailers gain the opportunity to tell a complete brand story while simultaneously boosting customer loyalty.

Source: CBX

Using the Store Banner to Endorse Private Label Architecture